Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)

Sinsin Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	790.23	346.46	2,240	799.33	2,504	1,130
Short-Term Investments	-	-	-	-	-	280
Cash & Short-Term Investments	790.23	346.46	2,240	799.33	2,504	1,410
Cash Growth	-37.39%	-84.53%	180.24%	-68.08%	77.61%	-35.14%
Accounts Receivable	32,223	27,975	25,771	23,237	22,526	24,269
Other Receivables	2,718	2,216	1,953	1,652	1,479	1,538
Receivables	34,940	30,191	27,724	24,889	24,005	25,807
Inventory	15,596	15,733	14,390	10,370	12,371	12,966
Prepaid Expenses	227.01	160.45	34.91	33.79	70.89	30.73
Other Current Assets	777.24	676.95	659.08	375.07	729.2	4,376
Total Current Assets	52,331	47,108	45,048	36,467	39,680	44,589
Property, Plant & Equipment	66,823	68,264	66,825	69,345	70,034	80,219
Long-Term Investments	3,275	3,270	3,559	3,183	3,180	110.03
Other Intangible Assets	580.71	586.32	592.29	499.07	499.07	585.55
Long-Term Accounts Receivable	-0	-0	-0	-0	1.84	25.44
Long-Term Deferred Tax Assets	1,611	1,612	1,400	1,394	1,184	44.77
Other Long-Term Assets	3,762	3,570	3,790	3,418	3,555	3,664
Total Assets	128,383	124,409	121,213	114,307	118,134	129,238
Accounts Payable	6,591	7,060	6,815	4,746	6,911	6,071
Accrued Expenses	993.66	845.07	864.38	784.18	647.39	627.36
Short-Term Debt	19,041	16,142	11,794	12,720	9,916	14,750
Current Portion of Long-Term Debt	18,521	18,384	12,629	8,590	8,205	5,436
Current Portion of Leases	158.01	76.79	132.21	116.44	71.6	146.54
Current Income Taxes Payable	175.17	169.82	186.45	-	1,678	-
Current Unearned Revenue	-	-	-	-	-	57.69
Other Current Liabilities	10,995	9,042	9,907	6,962	6,954	7,694
Total Current Liabilities	56,474	51,720	42,327	33,919	34,382	34,782
Long-Term Debt	6,832	9,843	18,865	24,676	26,857	33,310
Long-Term Leases	177.93	59.01	61.44	133.54	127.43	217.73
Long-Term Unearned Revenue	-	-	-	-	-	3,142
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,046
Other Long-Term Liabilities	755.29	335.37	313.31	580.1	210	210
Total Liabilities	64,240	62,319	61,682	59,507	62,086	72,867
Common Stock	7,585	7,585	7,585	7,585	7,585	7,585
Additional Paid-In Capital	14,450	14,450	14,450	14,450	14,450	14,450
Retained Earnings	43,143	41,019	37,478	32,890	34,150	34,336
Comprensive Income & Other	-775.65	-759.18	184.15	1.31	9.58	-9.05
Total Common Equity	64,403	62,295	59,698	54,927	56,195	56,363
Minority Interest	-260.6	-204.62	-166.81	-126.43	-147.38	7.8
Shareholders' Equity	64,143	62,090	59,531	54,800	56,048	56,371
Total Liabilities & Equity	128,383	124,409	121,213	114,307	118,134	129,238
Total Debt	44,730	44,505	43,481	46,236	45,177	53,860
Net Cash (Debt)	-43,939	-44,158	-41,241	-45,437	-42,673	-52,450
Net Cash Per Share	-2896.37	-2910.81	-2718.51	-2995.06	-2812.89	-3457.39
Filing Date Shares Outstanding	15.17	15.17	15.17	15.17	15.17	15.17
Total Common Shares Outstanding	15.17	15.17	15.17	15.17	15.17	15.17
Working Capital	-4,144	-4,612	2,720	2,548	5,297	9,807
Book Value Per Share	4245.30	4106.33	3935.14	3620.62	3704.24	3715.31
Tangible Book Value	63,823	61,709	59,106	54,428	55,696	55,778
Tangible Book Value Per Share	4207.02	4067.68	3896.09	3587.73	3671.34	3676.71
Land	13,944	13,944	13,860	13,722	13,722	11,837
Buildings	44,349	44,264	44,093	43,922	43,138	3,915
Machinery	32,972	32,628	27,545	26,864	25,014	15,015
Construction In Progress	-	-	-	-	-	63,863

Source: S&P Capital IQ. Standard template. Financial Sources.